Literature DB >> 27072190

Finally, safe and effective treatment options for hepatitis C in hemodialysis patients.

Kalyan Ram Bhamidimarri1, Paul Martin2.   

Abstract

Entities:  

Keywords:  Direct acting antivirals; End-stage renal disease; HCV

Mesh：

Year:  2016        PMID： 27072190     DOI： 10.1016/j.jhep.2016.04.003

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  7 in total

1.  Grazoprevir plus elbasvir and other treatment options in hepatitis C infected patients with stage 4-5 chronic kidney disease.

Authors:  Kalyan Ram Bhamidimarri
Journal:  Ann Transl Med       Date:  2016-10

2.  Preliminary experience with sofosbuvir-based treatment regimens for patients dependent on hemodialysis.

Authors:  Rajiv Mehta; Ketan Desai; Mayank Kabrawala; Subhash Nandwani; Jatin Shah; Nisha Desai; Viral Parekh
Journal:  Indian J Gastroenterol       Date:  2018-01

3.  Treatment of chronic hepatitis C with sofosbuvir in a hemodialysis patient: a case report.

Authors:  Marius Djoumbissie Tchoupe; Hanen Chaker; Mona Boudabbous; Salma Toumi; François Pegdebamba Kissou; Saba Gargouri; Khawla Kammoun; Faiçal Jarraya; Nabil Tahri; Soumaya Yaich; Mohamed Ben Hmida
Journal:  Pan Afr Med J       Date:  2021-02-08

4.  Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus.

Authors:  Rita Chelly Felix Tavares; Ana Cristina de Castro Amaral Feldner; João Renato Rebello Pinho; Fernanda de Mello Malta; Roberto José Carvalho-Filho; Rúbia Anita Ferraz Santana; Vanessa Fusco Duarte de Castro; Gregório Tadeu Fernando Dastoli; Juliana Custódio Lima; Maria Lucia Cardoso Gomes Ferraz
Journal:  Infect Drug Resist       Date:  2018-10-25       Impact factor: 4.003

Review 5.  Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals.

Authors:  Soon Young Ko; Won Hyeok Choe
Journal:  Clin Mol Hepatol       Date:  2018-03-16

6.  Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease.

Authors:  Elena Laura Iliescu; Adriana Mercan-Stanciu; Letitia Toma
Journal:  BMC Nephrol       Date:  2020-01-16       Impact factor: 2.388

7.  Effectiveness of direct-acting antivirals in maintenance hemodialysis patients complicated with chronic hepatitis C.

Authors:  Chunhong Li; Jing Liang; Huiling Xiang; Haiyan Chen; Jie Tian
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.817
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.